Error in Figure/Table
In the published article, there was an error in Figure 4 as published. The microscopy slides of migration of “Vector” group and “PIGR+ LAMB3” group were misused in Figure 4G due to carelessness. The corrected Figure 4 and its caption appear below.
Figure 4
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
colorectal cancer, polymeric immunoglobulin receptor, prognostic marker, AKTFOXO3/4 axis, methylation-driven gene
Citation
Zhang D, Huang H, Zheng T, Zhang L, Cui B, Liu Y, Tan S, Zhao L, Tian T, Gao L, Fu Q, Cheng Z and Zhao Y (2022) Corrigendum: Polymeric immunoglobulin receptor suppresses colorectal cancer through the AKT-FOXO3/4 axis by downregulating LAMB3 expression. Front. Oncol. 12:1012871. doi: 10.3389/fonc.2022.1012871
Received
06 August 2022
Accepted
08 August 2022
Published
22 August 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2022
Updates
Copyright
© 2022 Zhang, Huang, Zheng, Zhang, Cui, Liu, Tan, Zhao, Tian, Gao, Fu, Cheng and Zhao.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yashuang Zhao, zhao_yashuang@263.net
This article was submitted to Gastrointestinal Cancers: Colorectal Cancer, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.